ADAM17 and Sepsis: With the predetermined efficacy of ADAM17 knocking out leukocytes in increasing neutrophil recruitment and reducing bacterial spread during polymicrobial sepsis [117], Mishra et al. investigated the efficacy of ADAM17 mAb MEDI3622 against a murine model of polymicrobial sepsis [118].